...Unidentified Participant Absci is an AI drug creation company that aims to create higher-quality biologics for patients at a more effective rate. Instead of looking for drugs like a needle in a haystack, the company creates them in-silico using generative AI to screen billions of cells each week. The company has roughly high-teens active programs and generates roughly 3 billion protein interaction data points weekly. Great to have you here with us, guys. I think a good place to start would be if you guys could just provide a brief overview of Absci and, more importantly, what the role of generative AI is and the role that it plays in the products and services that you provide. Unidentified Company Representative Thanks, Joe. Microphone check. Good? So Absci is deploying generative AI at scale to design new drugs, biologics. And I think the history of the company started as a syn-bio company, so we're really a data-first company if you think about it. The first eight years of the company's...